ALTAVOL Trademark

Trademark Overview


On Monday, January 15, 2024, a trademark application was filed for ALTAVOL with the United States Patent and Trademark Office. The USPTO has given the ALTAVOL trademark a serial number of 79395459. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, February 10, 2025. This trademark is owned by Novartis AG. The ALTAVOL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in the treatment of hematology diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and ...

Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention, and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention, and treatment of hematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention, and treatment of eye diseases and ...
altavol

General Information


Serial Number79395459
Word MarkALTAVOL
Filing DateMonday, January 15, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, February 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in the treatment of hematology diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in the treatment of ophthalmology diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Goods and ServicesMedical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention, and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention, and treatment of hematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention, and treatment of eye diseases and eye conditions; medical apparatus and instruments for the diagnosis, prevention, and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of immune system diseases and disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of kidney diseases; medical apparatus and instruments for the diagnosis, prevention, and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention, and treatment of hypertension; medical apparatus and instruments for the diagnosis, prevention, and treatment of skin disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of urinary diseases and disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of ophthalmological diseases and disorders; medical apparatus and instruments for the diagnosis, prevention, and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention, and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention, and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention, and treatment of respiratory diseases and asthma; radiological apparatus for medical purposes and instruments being radiological apparatus for medical purposes; genetic testing apparatus for medical purposes and instruments being genetic testing apparatus for medical purposes; electromagnetic drug delivery apparatus for medical use and instruments being electromagnetic drug delivery apparatus for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments being medical diagnostic apparatus for testing DNA and RNA samples for medical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments being medical apparatus for introducing pharmaceutical preparations into the human body

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Friday, May 10, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, May 15, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, May 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 21, 2024APPLICATION FILING RECEIPT MAILED
Monday, December 16, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 29, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, August 9, 2024ASSIGNED TO EXAMINER
Tuesday, December 17, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 2, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 17, 2025REFUSAL PROCESSED BY IB
Monday, February 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 2, 2025REFUSAL PROCESSED BY MPU